Insider Buying Boosts Confidence in Exagen’s Autoimmune Diagnostic Future
Insider buying of Exagen Inc. signals confidence in its autoimmune testing pipeline, digital AI integration, and value‑based reimbursement strategy— a boost for niche diagnostic investors.
4 minutes to read